Clin2
NCT07436234Possibly a fitNot yet recruiting

Investigational drug for seasonal hay fever symptoms

Seasonal Allergic Rhinitis

Treatments studied

Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.

This study tests an investigational drug called AK139 to see if it can better control seasonal allergic rhinitis (hay fever) symptoms like sneezing and runny nose. If your symptoms are not well managed with current allergy medicines, this trial might offer a new option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
111 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have had seasonal allergic rhinitis (hay fever) for at least 2 years.
  • Your hay fever symptoms were not fully controlled by standard allergy medicines (like steroid nasal sprays) last pollen season.
  • You have a confirmed allergy to at least one pollen in your area.
  • You do not have other types of rhinitis or nasal conditions that could affect the study.
  • You must use effective birth control during the study and for 3 months after the last dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06846385Recruiting· Phase 2/Phase 3
Testing a new shot for severe seasonal hay fever

This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.

Beijing, Beijing Municipality
NCT07146126Not yet recruiting· Phase 3
Nasal spray for seasonal allergy symptoms

This trial tests a new nasal spray designed to relieve the stuffy nose, sneezing, and itching caused by seasonal allergies. It is for people with moderate to severe symptoms that aren’t controlled by other treatments.

Beijing, Beijing Municipality
NCT07688772Recruiting· Phase 3
Study of SHR-1819 Injection for Seasonal Allergic Rhinitis

This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.

Beijing, Beijing Municipality
NCT07398859Recruiting· Phase 2
New injection for seasonal allergy symptoms

This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.

Beijing, Beijing Municipality
NCT04815668Recruiting
Acupuncture for moderate-to-severe seasonal allergy rhinitis

This trial tests whether acupuncture at a specific spot behind the nose can reduce symptoms from seasonal allergies (triggered by things like grass or birch pollen). It may help if your allergy symptoms are moderate to severe and have lasted for a long time.

Beijing
NCT07711262Recruiting· Phase 3
Study of Rupatifen for seasonal allergic rhinitis

This trial tests an experimental capsule called Rupatifen for adults with seasonal allergies. It aims to see if it reduces symptoms like sneezing, runny nose, and congestion during spring or fall allergy seasons.

Baoding, Hebei

Hear when a new Seasonal Allergic Rhinitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.